Lewis J. Rose MD
Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology
Associate Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ
Join to view full profile
10800 Knights RdPhiladelphia, PA 19114
Phone+1 215-890-3030
Fax+1 215-890-3031
Dr. Rose is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lewis Rose is an oncologist based in Philadelphia, PA, with subspecialties in breast cancer, gastrointestinal cancer, and hematologic oncology. He graduated from Harvard Medical School in 1978 and completed his residency in internal medicine at Sidney Kimmel Medical College, followed by a fellowship in hematology and medical oncology at the University of Pennsylvania Health System. Dr. Rose has served as a Clinical Associate Professor of Medical Oncology at Kimmel Cancer Center from 2008 to 2014. His experience includes working with conditions such as amyloidosis, cancer-associated retinopathy, breast cancer, and lung cancer. He has contributed to research with publications in reputable journals and has been involved in multiple clinical trials. Dr. Rose has been recognized with several certifications and honors, including the CMS Meaningful Use Stage 1 and 2 Certifications and Patient-Centered Specialty Practice Recognition.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1981 - 1984
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1978 - 1981
Harvard Medical SchoolClass of 1978
Certifications & Licensure
DE State Medical License 2017 - 2027
NJ State Medical License 2017 - 2027
PA State Medical License 1979 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014, 2017
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
Clinical Trials
- Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2009 Feb 05
- A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer Start of enrollment: 2011 May 25
- Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Publications & Presentations
PubMed
- 2 citationsPhase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.Jonathan Pan, Sushil Ghimire, S. Onder Alpdogan, Andrew E. Chapman, Matthew Carabasi
Leukemia & Lymphoma. 2021-02-23 - 3 citationsCommon Variable Immunodeficiency Disease and Rectal Squamous Cell Carcinoma: a Case Report of a Rare Syndromic Tumor Type.Allison F. Goldberg, Lewis J. Rose, Peter A. McCue
Journal of Gastrointestinal Cancer. 2016-12-01 - 4 citationsColposcopic and cytologic detection of chronic lymphocytic leukemia in the vagina: a case report.Marina Katsnelson, Raeph Laughingwell, Lewis J. Rose, Norman G. Rosenblum
The Journal of Reproductive Medicine. 2011-07-01
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
